Market Overview

15 Biggest Mid-Day Gainers For Thursday

  • GlycoMimetics Inc (NASDAQ: GLYC) shares jumped 67.6 percent to $9.00 as the company reported that GMI-1271 has received the FDA Breakthrough therapy designation for adult relapsed/refractory acute myeloid leukemia.
  • athenahealth, Inc (NASDAQ: ATHN) shares surged 16 percent to $123.30 following a 13D filing from Elliott Associates showing a 9.2 percent stake in the company.
  • Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares gained 14 percent to $4.31. Leerink Swann upgraded Achillion Pharmaceuticals from Market Perform to Outperform.
  • CytRx Corporation (NASDAQ: CYTR) rose 12.1 percent to $ 0.508. CytRx will present global Phase 3 aldoxorubicin clinical data in patients with soft tissue sarcomas at the 2017 ASCO Annual Meeting.
  • ImmunoGen, Inc. (NASDAQ: IMGN) shares climbed 11.4 percent to $5.27 as the company disclosed promising new clinical data with mirvetuximab soravtansine in ovarian cancer.
  • Veritiv Corp (NYSE: VRTV) gained 9.2 percent to $43.62. Wells Fargo upgraded Veritiv from Market Perform to Outperform.
  • Perry Ellis International, Inc. (NASDAQ: PERY) rose 8.5 percent to $19.66 after the company reported stronger-than-expected Q1 results.
  • Incyte Corporation (NASDAQ: INCY) gained 7.9 percent to $130.02 Incyte disclosed that its IDO1 enzyme inhibitor in combo with Merck's anti-PD-1 therapy is 'well-tolerated and demonstrated durable clinical responses across multiple solid tumors'. The company also announced that first data from combo of epacadostat with Bristol-Myers' opdivo showed that combo is 'well-tolerated and demonstrates promising clinical outcomes in multiple advanced solid tumors.'
  • Pandora Media Inc (NYSE: P) rose 5.3 percent to $9.41. Sirius XM Holdings Inc. (NASDAQ: SIRI) is in talks about bidding for Pandora, according to sources as reported by the New York Post.
  • L Brands Inc (NYSE: LB) gained 5 percent to $50.80 after the company reported upbeat earnings for its first quarter and raised its FY17 outlook.
  • Syndax Pharmaceuticals Inc (NASDAQ: SNDX) shares gained 5 percent to $14.26 after surging 44.62 percent on Wednesday. Syndax issued results from Phase 2 ENCORE 601 trial of entinostat in combo with Merck's KEYTRUDA for the treatment of advanced melanoma.
  • Teladoc Inc (NYSE: TDOC) shares surged 4.9 percent to $28.90. KeyBanc initiated coverage of Teladoc with an Overweight rating.
  • Shire PLC (ADR) (NASDAQ: SHPG) shares rose 4 percent to $189.50 after the company disclosed that its lanadelumab study met primary endpoint.
  • Affimed NV (NASDAQ: AFMD) shares rose 3.4 percent to $2.33. Affimed reported that it will present immune cell engager data at the American Society of Clinical Oncology Annual Meeting and EACR-AACR-SIC Special Conference.
  • Childrens Place Inc (NASDAQ: PLCE) rose 2.6 percent to $114.50 after the company posted upbeat quarterly profit.

Related Articles (ACHN + AFMD)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Analyst Ratings Movers

Latest Ratings

ESSBMO CapitalUpgrades255.0
ESRTBMO CapitalUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at